These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21855131)

  • 1. Inflammatory responses to pulmonary application of PEI-based siRNA nanocarriers in mice.
    Beyerle A; Braun A; Banerjee A; Ercal N; Eickelberg O; Kissel TH; Stoeger T
    Biomaterials; 2011 Nov; 32(33):8694-701. PubMed ID: 21855131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice.
    Beyerle A; Braun A; Merkel O; Koch F; Kissel T; Stoeger T
    J Control Release; 2011 Apr; 151(1):51-6. PubMed ID: 21223987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
    Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T
    Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene imine) nanocarriers do not induce mutations nor oxidative DNA damage in vitro in MutaMouse FE1 cells.
    Beyerle A; Long AS; White PA; Kissel T; Stoeger T
    Mol Pharm; 2011 Jun; 8(3):976-81. PubMed ID: 21446747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
    Huang HY; Kuo WT; Chou MJ; Huang YY
    J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications.
    Beyerle A; Irmler M; Beckers J; Kissel T; Stoeger T
    Mol Pharm; 2010 Jun; 7(3):727-37. PubMed ID: 20429563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships.
    Beyerle A; Merkel O; Stoeger T; Kissel T
    Toxicol Appl Pharmacol; 2010 Jan; 242(2):146-54. PubMed ID: 19822165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.
    Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T
    Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
    Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
    Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-related off-target effects in non-viral siRNA delivery.
    Merkel OM; Beyerle A; Beckmann BM; Zheng M; Hartmann RK; Stöger T; Kissel TH
    Biomaterials; 2011 Mar; 32(9):2388-98. PubMed ID: 21183213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.
    Zintchenko A; Philipp A; Dehshahri A; Wagner E
    Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
    Fattal E; Bochot A
    Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.
    Chen J; Tian H; Guo Z; Xia J; Kano A; Maruyama A; Jing X; Chen X
    Macromol Biosci; 2009 Dec; 9(12):1247-53. PubMed ID: 19890950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA transfection by dendritic core-shell nanocarriers.
    Fischer W; Claderon M; Ofek P; Satchi-Fainaro R; Haag R
    J Control Release; 2010 Nov; 148(1):e89. PubMed ID: 21529651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.